Author

L. Cari

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:metabolomics· 1

Frequent Co-Authors

A. Mencacci· 1 shared A. Zampella· 1 shared B. Catalanotti· 1 shared B. Charlier· 1 shared B. Fiorillo· 1 shared C. Di Giorgio· 1 shared C. Massa· 1 shared C. Monari· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Mencacci

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Reduction of fungal dysbiosis is involved in the attenuation of Dextran Sodium Sulfate-Induced Mouse Colitis Mediated by GILZ protein and yeast extract compound

M. Gentili, E. Nunzi, S. Sabbatini, E. Lusenti, L. Cari, A. Mencacci, N. Ballet, G. Migliorati, C. Riccardi, S. Ronchetti, C. Monari

This study shows that combining GILZ protein and yeast extract reduces fungal dysbiosis and inflammation in DSS-induced colitis in mice.

bioRxiv · Jun 18, 2024 · PreprintMicrobiology

A microbial derived bile acid acts as GPBAR1 agonist and RORγt inverse agonist and reverses inflammation in inflammatory bowel disease

M. Biagioli, C. Di Giorgio, C. Massa, S. Marchiano', R. Bellini, M. Bordoni, G. Urbani, R. Roselli, G. Lachi, E. Morretta, F. Dal Piaz, B. Charlier, B. Fiorillo, B. Catalanotti, L. Cari, , S. Fiorucci

This study identifies 3-oxo-DCA as a microbial bile acid that acts as a GPBAR1 agonist and RORγt inverse agonist, reversing inflammation in IBD.

bioRxiv · Apr 8, 2024 · PreprintImmunology